Tempest Therapeutics
ID: 5330645Tempest Therapeutics is a small Molecules for Immuno-Oncology.
2
Funding Rounds
$85.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| To* Du****** | - | - | - |
| To* Wo***** | - | - | - |
| Ch******* Pe******** | - | - | |
| Mi** Ra** | - | - | |
| Ge*** Ni**** | - | - | - |
| Ro*** Si****** | - | - | - |
Funding series
Funding Series Analysis
The company Tempest Therapeutics has raised a total of $15m in funding over 2 rounds.
Key Insights:
- Tempest Therapeutics Funding Round, May 2022: $15m
- Tempest Therapeutics funding round, March 2018: $70m
Industries
Tempest Therapeutics is active in the following industries: